Lista de obras - Paolo Macor - Dominio Público Uruguay

A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome.

artículo científico publicado en 2014

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

artículo científico publicado en 2016

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

artículo científico publicado en 2014

C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function

scientific article published on 29 January 2009

Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I

artículo científico publicado en 2020

Complement C1q and C8 deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness

artículo científico publicado en 2008

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma

artículo científico publicado en 2006

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

artículo científico publicado en 2015

Complement as effector system in cancer immunotherapy.

artículo científico publicado en 2007

Complement in human diseases: Lessons from complement deficiencies

artículo científico publicado en 2009

Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.

artículo científico publicado en 2005

Critical Role and Therapeutic Control of the Lectin Pathway of Complement Activation in an Abortion-Prone Mouse Mating

artículo científico publicado en 2015

Cubosomes for in vivo fluorescence lifetime imaging

artículo científico publicado en 2016

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

artículo científico publicado en 2014

Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma.

artículo científico publicado en 2010

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

Humoral immunotherapy of multiple myeloma: perspectives and perplexities.

artículo científico publicado en 2010

In vivo Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab

artículo científico publicado en 2007

In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging

scientific article published on 01 November 2008

Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis

artículo científico publicado en 2016

Meniscal Ossicles as micro-CT Imaging Biomarker in a Rodent Model of Antigen-Induced Arthritis: a Synchrotron-Based X-ray Pilot Study

artículo científico

NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

artículo científico publicado en 2015

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats

scholarly article by Paolo Durigutto et al published April 2019 in Haematologica

New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles

artículo científico publicado en 2013

P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.

artículo científico publicado en 2009

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

artículo científico publicado en 2018

Phage display technology for human monoclonal antibodies

artículo científico publicado en 2014

Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia

artículo científico publicado en 2014

Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5.

artículo científico publicado en 2013

Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats

scientific article published on 01 April 2007

Simple scale-up of recombinant antibody production using an UCOE containing vector.

artículo científico publicado en 2011

Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

artículo científico publicado en 2015

The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target

scientific article published on 24 February 2020

The development of atypical hemolytic uremic syndrome depends on complement C5

artículo científico publicado en 2011

Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5

artículo científico publicado en 2012

Lista de obras de Paolo Macor

A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome.

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers.

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function

Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I

Complement C1q and C8 deficiency in an individual with recurrent bacterial meningitis and adult-onset systemic lupus erythematosus-like illness

Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

Complement as effector system in cancer immunotherapy.

Complement in human diseases: Lessons from complement deficiencies

Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.

Critical Role and Therapeutic Control of the Lectin Pathway of Complement Activation in an Abortion-Prone Mouse Mating

Cubosomes for in vivo fluorescence lifetime imaging

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma.

Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia

Humoral immunotherapy of multiple myeloma: perspectives and perplexities.

In vivo Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab

In vivo biodistribution and lifetime analysis of cy5.5-conjugated rituximab in mice bearing lymphoid tumor xenograft using time-domain near-infrared optical imaging

Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis

Meniscal Ossicles as micro-CT Imaging Biomarker in a Rodent Model of Antigen-Induced Arthritis: a Synchrotron-Based X-ray Pilot Study

NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats

New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles

P-selectin glycoprotein ligand-1 as a potential target for humoral immunotherapy of multiple myeloma.

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

Phage display technology for human monoclonal antibodies

Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia

Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5.

Selective therapeutic control of C5a and the terminal complement complex by anti-C5 single-chain Fv in an experimental model of antigen-induced arthritis in rats

Simple scale-up of recombinant antibody production using an UCOE containing vector.

Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target

The development of atypical hemolytic uremic syndrome depends on complement C5

Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5